Segment Reporting and Significant Concentration - Schedule of Reconciliation of Consolidated Net Income (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Cost of revenue:
Research and development		$ 158,194	$ 143,201	$ 137,913
Stock-based compensation		33,564	28,990	27,243
Net income		86,852	66,246	44,060
Consolidated net income		86,852	66,246	44,060
Operating Segments [Member]
Revenue		1,197,248	1,169,258	1,089,752
Cost of revenue:
Transaction fees		97,857	87,430	75,679
All other	[1]	513,237	530,109	488,934
Total cost of revenue		611,094	617,539	564,613
Research and development	[1]	155,638	142,962	137,102
Selling and marketing	[1]	114,323	114,207	111,693
General and administrative	[1]	116,761	108,823	107,513
Restructuring and reorganization charges	[1]	13,323	16,336	46,308
Stock-based compensation		34,385	29,480	27,945
Other segment items	[2]	8,983	16,384	17,365
Interest expense		30,469	31,176	16,432
Income tax provision		25,420	26,105	16,721
Net income		86,852	66,246	44,060
Consolidated net income		86,852	66,246	44,060
Eliminations and Reconciling Items [Member]
Cost of revenue:
Net income		$ 0	$ 0	$ 0

[1] These functional expense lines include depreciation expense, which is presented separately on our Income Statements.

[2] Other segment items include acquisition-related costs (both transaction-related and amortization of acquired intangible assets), executive transition costs, interest income, loss on derivative liability upon debt conversion, and foreign currency gains/losses.